Skip to main content
Duke University Libraries
View Item 
  •   DukeSpace
  • Duke Scholarly Works
  • Scholarly Articles
  • View Item
  •   DukeSpace
  • Duke Scholarly Works
  • Scholarly Articles
  • View Item
    • Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Implant healing in experimental animal models of diabetes.

    Thumbnail
    View / Download
    4.6 Mb
    Date
    2011-05-01
    Authors
    Klitzman, Bruce
    Le, NN
    Levinson, H
    Rose, MB
    Repository Usage Stats
    327
    views
    227
    downloads
    Abstract
    Diabetes mellitus is becoming increasingly prevalent worldwide. Additionally, there is an increasing number of patients receiving implantable devices such as glucose sensors and orthopedic implants. Thus, it is likely that the number of diabetic patients receiving these devices will also increase. Even though implantable medical devices are considered biocompatible by the Food and Drug Administration, the adverse tissue healing that occurs adjacent to these foreign objects is a leading cause of their failure. This foreign body response leads to fibrosis, encapsulation of the device, and a reduction or cessation of device performance. A second adverse event is microbial infection of implanted devices, which can lead to persistent local and systemic infections and also exacerbates the fibrotic response. Nearly half of all nosocomial infections are associated with the presence of an indwelling medical device. Events associated with both the foreign body response and implant infection can necessitate device removal and may lead to amputation, which is associated with significant morbidity and cost. Diabetes mellitus is generally indicated as a risk factor for the infection of a variety of implants such as prosthetic joints, pacemakers, implantable cardioverter defibrillators, penile implants, and urinary catheters. Implant infection rates in diabetic patients vary depending upon the implant and the microorganism, however, for example, diabetes was found to be a significant variable associated with a nearly 7.2% infection rate for implantable cardioverter defibrillators by the microorganism Candida albicans. While research has elucidated many of the altered mechanisms of diabetic cutaneous wound healing, the internal healing adjacent to indwelling medical devices in a diabetic model has rarely been studied. Understanding this healing process is crucial to facilitating improved device design. The purpose of this article is to summarize the physiologic factors that influence wound healing and infection in diabetic patients, to review research concerning diabetes and biomedical implants and device infection, and to critically analyze which diabetic animal model might be advantageous for assessing internal healing adjacent to implanted devices.
    Type
    Journal article
    Subject
    Animals
    Biosensing Techniques
    Blood Glucose
    Blood Glucose Self-Monitoring
    Candidiasis
    Cross Infection
    Cytokines
    Defibrillators, Implantable
    Diabetes Complications
    Fibrosis
    Humans
    Intercellular Signaling Peptides and Proteins
    Orthopedics
    Prostheses and Implants
    Prosthesis Failure
    Wound Healing
    Permalink
    https://hdl.handle.net/10161/9195
    Published Version (Please cite this version)
    10.1177/193229681100500315
    Publication Info
    Klitzman, Bruce; Le, NN; Levinson, H; & Rose, MB (2011). Implant healing in experimental animal models of diabetes. J Diabetes Sci Technol, 5(3). pp. 605-618. 10.1177/193229681100500315. Retrieved from https://hdl.handle.net/10161/9195.
    This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
    Collections
    • Scholarly Articles
    More Info
    Show full item record

    Scholars@Duke

    Klitzman

    Bruce Klitzman

    Associate Professor of Surgery
    Our overriding interests are in the fields of tissue engineering, wound healing, biosensors, and long term improvement of medical device implantation. My basic research interests are in the area of physiological mechanisms of optimizing substrate transport to tissue. This broad topic covers studies on a whole animal, whole organ, hemorheological, microvascular, cellular, ultrastructural, and molecular level. The current projects include: 1) control of blood flow and flow distribu
    Levinson

    Howard Levinson

    Associate Professor of Surgery
    Fibrosis Wound Healing Cell Contractility Tissue RemodelingMedical device development including hernia mesh, tissue engineered skin and wound care technologies
    Alphabetical list of authors with Scholars@Duke profiles.
    Open Access

    Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy

    Rights for Collection: Scholarly Articles

     

     

    Search Scope

    Browse

    All of DukeSpaceCommunities & CollectionsAuthorsTitlesTypesBy Issue DateDepartmentsAffiliations of Duke Author(s)SubjectsBy Submit DateThis CollectionAuthorsTitlesTypesBy Issue DateDepartmentsAffiliations of Duke Author(s)SubjectsBy Submit Date

    My Account

    LoginRegister

    Statistics

    View Usage Statistics